CA-LUMILEDS
28.2.2019 20:18:05 CET | Business Wire | Press release
Lumileds today announced the appointment of Dr. Jonathan Rich as Chief Executive Officer. Dr. Rich most recently served as Chairman and CEO of Berry Global, Inc., a Fortune 500 specialty materials and consumer packaging company, from 2010 to 2018. Dr. Rich succeeds Mark Adams, who is stepping down as CEO and from the board of directors but will remain in an advisory role to the company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190228005864/en/
“I am very pleased to be joining Lumileds and am looking forward to building on the company’s differentiated lighting technology foundation to increase the value we can deliver to customers across a broad set of industries,” said Dr. Rich. “The opportunity for lighting innovation to make a positive impact on safety and sustainability is tremendous.”
Before Dr. Rich held the position of Chairman and CEO of Berry Global, he was president and CEO at Momentive, a specialty chemical company headquartered in Albany, New York. Prior to that, he held positions with Goodyear Tire & Rubber Company, first as President of the Global Chemicals business and subsequently as President of Goodyear’s North American Tire Division. Dr. Rich spent his formative years at General Electric, first as a research scientist at GE Global Research and then in a series of management positions with GE Plastics. He received a Bachelor of Science degree in chemistry from Iowa State University and a Ph.D. in chemistry from the University of Wisconsin-Madison. He has been a visiting lecturer at Cornell University Johnson School of Business since 2017.
“Mark Adams has made significant contributions to Lumileds during his tenure, leading the transition to an independent company and cultivating a culture of innovation and customer focus,” said Rob Seminara, a senior partner at Apollo and chairman of the board of Lumileds. “On behalf of the Board of Directors of Lumileds, we would like to thank him for his service to the company and wish him the very best in his future endeavors. We are very excited Jon will be joining Lumileds to drive the next phase of innovation and growth and we look forward to working with him again.”
Added Adams: “It has been a great experience leading Lumileds’ transition to an independent company that is focused on delivering lighting solutions that truly make a positive impact in the world. I would like to thank the employees of Lumileds and the Apollo team for their support and wish the company much success in the future.”
About Lumileds:
For automotive, mobile, IoT and illumination companies that require innovative lighting solutions, Lumileds is a global leader, employing more than 9,000 team members operating in over 30 countries. Lumileds partners with its customers to push the boundaries of light.
To learn more about our portfolio of lighting solutions, visit lumileds.com .
About Apollo Global Management:
Apollo is a leading global alternative investment manager with offices in New York, Los Angeles, San Diego, Houston, Bethesda, London, Frankfurt, Madrid, Luxembourg, Mumbai, Delhi, Singapore, Hong Kong, Shanghai, and Tokyo. Apollo has assets under management of approximately $280 billion as of December 31, 2018 in private equity, credit and real assets funds invested across a core group of nine industries where Apollo has considerable knowledge and resources. For more information about Apollo, please visit www.apollo.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190228005864/en/
Contact:
Kyra Whitten Vice President, Corporate Communications Lumileds Kyra.Whitten@lumileds.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom